From dysbiosis to precision medicine: targeting the microbial–metabolic axis in IBD management
John K. Giju, Subin John, Amrutha Sivadas, Meera Prabhakar, Krishnakripa K., Damu Sunilkumar, Bipin G. Nair, Sanjay Pal, Vidhya Prakash · 2026
Read From dysbiosis to precision medicine: targeting the microbial–metabolic axis in IBD management by John K. Giju, Subin John, Amrutha Sivadas, Meera Prabhakar, Krishnakripa K., Damu Sunilkumar, Bipin G. Nair, Sanjay Pal, Vidhya Prakash (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13236684.txt.
Description
John K. Giju and co-authors reviewed in 2026 how gut microbes and their chemistry drive inflammatory bowel disease and how treatments might target that axis. The disease was once framed mainly as immune dysfunction, yet microbial imbalance now appears central to its development. Patient gut communities often lose helpful bacteria while pro-inflammatory types expand in the studies surveyed. Barrier damage and misdirected immune activation follow from that imbalance.
Microbial products such as short-chain fatty acids and bile acid derivatives strongly shape mucosal inflammation in the pathways reviewed. Standard drugs mostly suppress inflammation and can fail initially, stop working, or cause body-wide side effects. Candidate approaches include stool transplantation, probiotics, virus-based bacterial targeting, and even worm-based therapy. Engineering microbes and editing their genes may allow personal treatment in future. The authors argue fixing causes beats only calming symptoms.
Catalog record
| CREATOR | John K. Giju, Subin John, Amrutha Sivadas, Meera Prabhakar, Krishnakripa K., Damu Sunilkumar, Bipin G. Nair, Sanjay Pal, Vidhya Prakash |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 74 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |